Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer

Patients with colon cancer are often faced a high risk of disease recurrence within 5 years of treatment that is the major cause of cancer mortality. Reliable molecular markers were required to improve the most effective personalized therapy. Here, we identified a recurrence-associated six-lncRNA (l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Meng, Hu, Long, Zhang, Zicheng, Wu, Nan, Sun, Jie, Su, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076224/
https://www.ncbi.nlm.nih.gov/pubmed/30195788
http://dx.doi.org/10.1016/j.omtn.2018.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076224/
https://www.ncbi.nlm.nih.gov/pubmed/30195788
http://dx.doi.org/10.1016/j.omtn.2018.06.007

Ejemplares similares